Recently, a distinct TIL-B subset (IgG4+CD49b+CD73+) was reported to express proangiogenic cytokines in patients with esophageal cancer and melanoma (34). within the tumor immune microenvironment and propose potential B cell-based immunotherapeutic strategies, which may help promote cancer immunotherapy. Keywords: B-lymphocytes, tumor-infiltrating lymphocytes, tertiary lymphoid structures, humoral immunity, immunotherapy, tumor microenvironment, prognosis Introduction The host immune […]